Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Firebrick Pharma Limited ( (AU:FRE) ).
Firebrick Pharma Limited announced an investor webinar scheduled for February 25, 2025, to discuss half-year results, the launch of Nasodine Nasal Spray in new markets, and future plans for 2025. This event provides shareholders and potential investors with updates on the company’s strategy and an opportunity for engagement through a Q&A session.
More about Firebrick Pharma Limited
Firebrick Pharma is a pharmaceutical company focused on developing and commercializing novel formulations and uses of povidone-iodine (PVP-I). The company has launched Nasodine Nasal Spray and is expanding its market presence in regions such as the United States, Singapore, Fiji, and the South Pacific, with plans to enter the Philippines.
YTD Price Performance: 38.33%
Average Trading Volume: 145,791
Technical Sentiment Consensus Rating: Sell
See more insights into FRE stock on TipRanks’ Stock Analysis page.
